FCER1A and asthma: The finding that miR-155 expression was increased in human SMCs following FcεRI crosslinking was intriguing because miR-155 is known to be involved in the immune response (22) and has been implicated in allergic disease in humans including atopic dermatitis (23), allergic rhinitis (24), and asthma (25).